Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease

ClinicalTrials.gov ID: NCT02484547

Public ClinicalTrials.gov record NCT02484547. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 8:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Aducanumab (BIIB037) in Subjects With Early Alzheimer's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of the study is to evaluate the efficacy of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the Clinical Dementia Rating-Sum of Boxes (CDR-SB) score as compared with placebo in participants with early AD. Secondary objectives are to assess the effect of monthly doses of aducanumab as compared with placebo on clinical progression as measured by Mini-Mental State Examination (MMSE), AD Assessment Scale-Cognitive Subscale (13 items) \[ADAS-Cog 13\], and AD Cooperative Study-Activities of Daily Living Inventory (Mild Cognitive Impairment version) \[ADCS-ADL-MCI\].

Study identification

NCT ID
NCT02484547
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Biogen
Industry
Enrollment
1,643 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
50 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 15, 2015 (Actual)
Primary completion
Aug 5, 2019 (Actual)
Completion
Aug 5, 2019 (Actual)
Last update posted
Sep 2, 2021

2015 – 2019

United States locations

U.S. sites
58
U.S. states
23
U.S. cities
53
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35233 —
Banner Alzheimer's Institute Phoenix Arizona 85006 —
Xenoscience Inc. Phoenix Arizona 85013 —
Banner Sun Health Research Institute Sun City Arizona 85351 —
Institute for Memory Impairments Irvine California 92607 —
Renewal Behavioral Health Long Beach California 85013 —
USC Keck School of Medicine Los Angeles California 90033 —
Hoag Memorial Hospital Presbyterian Newport Beach California 92663 —
Excell Research, Inc. Oceanside California 92056 —
Pacific Neuroscience Medical Group Oxnard California 93030 —
Anderson Clinical Research Redlands California 92354 —
Pacific Research Network San Diego California 92103 —
University of California San Diego Medical Center San Diego California 92103 —
California Pacific Medical Center San Francisco California 94114 —
Syrentis Clinical Research Santa Ana California 92705 —
St Joseph Heritage Healthcare Santa Rosa California 95403 —
Stanford University Medical Center Stanford California 94305 —
University Of Colorado Denver Aurora Colorado 80045 —
IMMUNOe International Research Centers Thornton Colorado 80233 —
Associated Neurologists of Southern Connecticut, PC Fairfield Connecticut 06824 —
Yale University School Of Medicine New Haven Connecticut 06520 —
Research Center for Clinical Studies, Inc. Norwalk Connecticut 06851 —
JEM Research Institute Atlantis Florida 33462 —
Bradenton Research Center, Inc. Bradenton Florida 34205 —
Meridien Research Brooksville Florida 34601 —
Quantum Laboratories Inc. Deerfield Beach Florida 33064 —
Infinity Clinical Research, LLC Hollywood Florida 33021 —
Mayo Clinic in Florida Jacksonville Florida 32224 —
Renstar Medical Research Ocala Florida 34470 —
Clinical Neuroscience Solutions, Inc. Orlando Florida 32801 —
Axiom Clinical Research of Florida Tampa Florida 33609 —
Emory University Cognitive Neurology Clinic & ADRC Atlanta Georgia 30329 —
Medical Research Health and Education Foundation, Inc Columbus Georgia 31909 —
NeuroStudies.net, LLC Decatur Georgia 30033 —
Josephson, Wallack, Munshower Neurology, PC Indianapolis Indiana 46256 —
McLean Hospital Belmont Massachusetts 02478 —
Boston Center for Memory Newton Massachusetts 05201 —
Hattiesburg Clinic, PA Hattiesburg Mississippi 39401 —
Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas Nevada 89106 —
ActivMed Practices & Research Portsmouth New Hampshire 03801 —
AdvanceMed Research Lawrenceville New Jersey 08648 —
Empire Neurology, PC Latham New York 12110 —
Weill Cornell Medical College-New York Presbyterian Hospital New York New York 10021 —
Mount Sinai School of Medicine New York New York 10029 —
PMG Research of Winston-Salem, LLC Winston-Salem North Carolina 27103 —
Wake Forest Baptist Health Winston-Salem North Carolina 27103 —
Ohio State University Medical Center Dublin Ohio 43017 —
Lehigh Center for Clinical Research, LLC Allentown Pennsylvania 18104 —
Penn Memory Center Philadelphia Pennsylvania 19104 —
Rhode Island Hospital Providence Rhode Island 02903 —
Roper St. Francis Healthcare North Charleston South Carolina 29406-6076 —
Senior Adult Specialty Research Austin Texas 78757 —
The Methodist Hospital Research Institute Houston Texas 77030 —
Clinical Trial Network Houston Texas 77074 —
University of Utah Health Sciences Center Salt Lake City Utah 84132 —
Clinical Neuroscience Research Association, Inc Bennington Vermont 05201 —
University of Washington Medical Center Seattle Washington 98195 —
Northwest Neurological, PLLC Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 122 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02484547, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 2, 2021 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02484547 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →